The Hanover (THG) Q4 2025 earnings review
Record Earnings Mask Top-Line Deceleration
The Hanover delivered a record-breaking Q4 with Operating EPS of $5.79 (+8.8% YoY) and an Operating ROE of 23.1%, primarily driven by a spectacular turnaround in Personal Lines and a 25% surge in investment income. However, the growth narrative is losing steam. Net Written Premiums grew just 3.0%, the slowest pace of FY25, decelerating from 4.5% in Q3. While profitability is elite (89.0% Combined Ratio), the cooling top-line suggests the company is trading volume for margin, particularly in Core Commercial where growth was a meager 2.5%.
🐂 Bull Case
The margin recovery in Personal Lines is complete and impressive. The segment delivered an 85.5% Combined Ratio (down from 88.1% a year ago), with an underlying ex-CAT ratio of 85.4%. Pricing power remains strong with renewal increases of 9.2%.
Net Investment Income surged 25% YoY to $125.8M. With a fixed maturity portfolio yielding 4.44% (up from 3.97% last year) and strong operating cash flows, this provides a durable floor for earnings growth regardless of underwriting cycles.
🐻 Bear Case
Top-line momentum has stalled. Total NPW growth decelerated to 3.0%, with Core Commercial slowing to 2.5% and Specialty at just 1.2%. If pricing power fades, volume growth is currently insufficient to drive significant earnings expansion.
Despite favorable underlying metrics, Core Commercial reported a 96.1% Combined Ratio, deteriorating from 95.0% last year due to higher catastrophe losses (4.8 points). This segment remains sensitive to weather and large loss events.
⚖️ Verdict: 🟢
Bullish. While the deceleration in premium growth is a valid concern, the earnings quality is undeniable. An ROE of 23% and a Combined Ratio of 89% indicate a highly disciplined underwriter. The balance sheet is robust (BVPS +27% YoY), and the Personal Lines turnaround provides significant earnings stability.
Key Themes
Personal Lines Profitability Engine
Personal Lines has shifted from a remediation story to a profit engine. The segment Combined Ratio improved 2.6 points YoY to 85.5%. This was driven by a 'benefit of earned pricing outpacing loss trends' and lower property frequency. With renewal price increases of 9.2%, margins appear durable.
Investment Income Surge
Accelerating. Net Investment Income (NII) reached $125.8M in Q4, up 24.9% YoY. This acceleration is driven by higher reinvestment rates (new money yields) and portfolio rotation. NII now contributes over half of Operating Income, significantly dampening underwriting volatility.
Core Commercial Growth Deceleration
Decelerating. Core Commercial Net Premiums Written grew only 2.5% in Q4, a marked slowdown from 7.5% in the prior year and 3.5% in Q3. Middle Market actually contracted (-1.1%), masked only by Small Commercial growth (+4.8%). This suggests competitive pressures or a deliberate pullback in risk appetite.
Tax Rate Headwind
The effective tax rate spiked to ~24% in Q4 (vs typically lower rates), which management attributed to 'unusually high state income taxes.' While Operating Income absorbed this impact, persistent tax headwinds could drag on EPS growth relative to peers with more favorable domiciles.
Capital Return & Book Value
Book Value per Share hit $100.90, up 27.4% YoY. The company raised its dividend by 5.6% (21st consecutive annual increase) and repurchased $130M in shares for the full year. With robust statutory capital ($3.34B), the capacity for continued returns remains high.
Other KPIs
Accelerating. Up 9% from $5.32 in 24Q4 and up sequentially from $5.09 in 25Q3. The company is generating record earnings power despite muted top-line growth.
Improving. Down from 89.2% in 24Q4. The improvement was aided by very low catastrophe losses (1.7 points vs historical averages of 4-6 points). The underlying Ex-CAT combined ratio was a healthy 87.3%.
Reversing. While still highly profitable at 83.9%, the Combined Ratio deteriorated from 81.6% in 24Q4. Net favorable reserve development slowed (5.3 points vs 7.0 points last year), indicating that the massive reserve release tailwind may be normalizing.
Guidance
Management stated they are positioned for 'accelerated growth' in Specialty by focusing on smaller-sized accounts. However, actual Q4 data showed deceleration to 1.2% growth (vs 8.8% in 24Q4). This narrative contradicts the current print and requires monitoring.
Management enters 2026 with 'significant financial flexibility.' With $130M remaining in share repurchase capacity and a recent dividend hike, capital returns are expected to continue.
Key Questions
Core Commercial Growth Wall
Middle Market growth turned negative (-1.1%) this quarter. Is this a result of pricing discipline in a softening market, or are you losing market share to competitors?
Specialty Deceleration
Specialty growth slowed to 1.2% YoY despite the narrative of 'accelerated growth.' What specific lines are dragging down the segment, and when do you expect the numbers to align with the qualitative outlook?
Tax Rate Sustainability
Was the 24% tax rate a one-off true-up for the year, or should we model a structurally higher effective tax rate for FY26?